{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-066930","form_type":"8-K","ticker":"ORGO","cik":"0001661181","company_name":"Organogenesis Holdings Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.245784+00:00","generated_at":"2026-05-22T04:42:39.085950+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Organogenesis Q1 revenue down 21% to $86.7M; net loss widens to $18.8M; FY guidance reaffirmed","bullets":["Net revenue $86.7M, down 21% YoY; Advanced Wound Care fell 23% to $79.9M; Surgical & Sports Medicine up 11% to $6.8M.","Net loss $18.8M ($0.17 loss per share) vs $2.1M loss in Q1 2024; adjusted EBITDA loss $12.5M vs income $2.6M.","Cash $110.5M, no debt; cash used in operations $19.9M vs $10.2M in prior year.","FY2025 revenue guidance reaffirmed at $480M-$535M; updated net income guidance $4.7M-$34.0M (from prior range).","ReNu BLA submission on track for end of 2025; second phase 3 study patient enrollment expected by end of Q2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-066930","json":"https://secwatch.observer/filing/0000950170-25-066930.json","markdown":"https://secwatch.observer/filing/0000950170-25-066930.md","text":"https://secwatch.observer/filing/0000950170-25-066930.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661181/000095017025066930/0000950170-25-066930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661181/000095017025066930/orgo-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T04:42:39.085950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}